Polpharma Fine Chemicals Business Unit is building its position as an active supplier of generic APIs on the global market. The company strives to become a leading player in this market segment.
Vertical integration with the Pharma Business Unit gives us advantage in the area of quality and cost. At the same time we prove flexibility of the services provided.
Continuous innovation is the way to convert human capital and invested resources into value for our company. Polpharma encourages new ideas and transforms them into innovative applications to enhance our competitiveness.
Our goal is to understand the needs of our customers and provide optimum solutions.
We constantly seek ways to adding value to everything we do for our customers. We make sure to keep our API portfolio updated and expand it with new, attractive compounds.
Highly skilled and well motivated staff is Polpharma's greatest asset.
To complement in-house expertise we have developed a collaborative relationship with partnering laboratories and institutes.
Polpharma Pharmaceutical Works is a world-class manufacturer, and the largest producer of Active Pharmaceutical Ingredients (API) in Poland.
Our strategic imperative is the sustainable economic growth with environmental sustainability and sustainable working practices.
Product safety is our top priority. The last FDA inspection in February 2009 concluded with no Inspectional Observations Form - 483.